Uncompensated Care Negatively Hits HCA Holdings (HCA) 3Q Results
Leerink Partners maintained an Outperform rating on HCA Holdings (NYSE: HCA), and cut the price target to $79.00 (from $95.00) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
